Search

West Pharmaceutical Services Inc

Închisă

SectorSănătate

348.47 0.18

Rezumat

Modificarea prețului

24h

Curent

Minim

340.43

Maxim

349.64

Indicatori cheie

By Trading Economics

Venit

15M

154M

Vânzări

27M

872M

P/E

Medie Sector

44.551

68.51

EPS

2.37

Randament dividend

0.26

Marjă de profit

17.654

Angajați

10,800

EBITDA

-39M

179M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+16.05% upside

Dividende

By Acuity

Randament dividend

Medie Sector

0.26%

2.29%

Următoarele câștiguri

22 oct. 2026

Data viitoare de dividende

5 aug. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-404M

24B

Deschiderea anterioară

348.29

Închiderea anterioară

348.47

Sentimentul știrilor

By Acuity

50%

50%

175 / 340 Clasament în Healthcare

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 aug. 2026, 20:51 UTC

West Pharmaceutical Services shares declined in after-hours trading, shifting downward despite an initial gain. No specific company news was identified for the movement.

3 aug. 2026, 19:46 UTC

News

Citigroup raised its price target on West Pharmaceutical Services to $412, maintaining a Buy rating following strong quarterly results and increased revenue guidance.

31 iul. 2026, 23:01 UTC

News

West Pharmaceutical Services shares are lower in after-market trading despite strong Q2 results and raised full-year guidance, reflecting mixed market sentiment.

29 iul. 2026, 19:44 UTC

Macro Event

West Pharmaceutical Services is slightly lower amid broader market declines following the Federal Reserve's decision to keep interest rates steady.

28 iul. 2026, 23:31 UTC

West Pharmaceutical Services shares declined in after-market trading, tracking broader market losses amid rising competition in the semiconductor sector.

27 iul. 2026, 19:41 UTC

News

Evercore ISI raised its price target on West Pharmaceutical Services to $425, contributing to positive sentiment as shares trade higher since Friday's close.

24 iul. 2026, 22:01 UTC

West Pharmaceutical Services Inc shares are lower in after-market hours, continuing a trend of recent declines despite earlier volatility during the session.

22 iul. 2026, 22:51 UTC

West Pharmaceutical Services Inc shares are trading higher in after-market hours, supported by strong performance relative to their 20-day moving average and one-month range.

21 iul. 2026, 19:46 UTC

News

West Pharmaceutical Services has secured long-term agreements with Daikyo Seiko, enhancing its global reach. Shares are trading higher amid positive market momentum.

20 iul. 2026, 19:16 UTC

West Pharmaceutical Services is lower today, influenced by a notable decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

16.05% sus

Prognoză pe 12 luni

Medie 403.78 USD  16.05%

Maxim 447 USD

Minim 365 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

10 ratings

9

Cumpărare

1

Păstrare

0

Vânzare

Sentiment

By Acuity

175 / 340 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat